Table 5 Pharmaceutical companies displaying certification via PhRMA or EFPIA websites, which solicit data requests through email [47, 83, 84]
Pharmaceutical company and access point | Advertised trial data made available | Publicized date of earliest available data |
|---|---|---|
Almirall [108] | Study data for approved medications and indications in the US or EU | January 1, 2014 |
Study data submit for regulatory approval in the US and EU for approved indications | Unclear | |
Bial [110] clinical.trials@bial.com | Study data for approved medications and indications in the US or EU | Unclear |
Grunenthal [111] | Study data submit in support of licensed treatments in the US or EU | July 15, 2014 |
Study data for any approved product or products from discontinued trials which began since 2014 | January 1, 2000 | |
Lundbeck [114] | Study data for approved medications and indications in the US or EU | January 1, 2014 |
Study data for product indications approved in the US and EU | January 1, 2001 | |
Orion Pharma [117] Unclear request point | Study data for medications which have obtained received market authorisation | Unclear |
Otsuka [118] | Study data submit to the US or EU for regulatory approval | January 1, 2014 |
Shire [68] | Study data for compounds and indications approved in the US and EU | January 1, 2014 |
Vifor pharma [119] Unclear request point | Provide academic researchers access to clinical trial data upon request | Unclear |